SYH-2085

N/A

Report date: 2026/02/25 20:02:36
NME

Base Information

Drug NameSYH-2085
Drug Alias NameSYH2085SYH-2085
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolymerase acidic protein inhibitors
TargetsPolymerase acidic protein
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza B virus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesCspc Zhongqi Pharmaceutical Technology (Tianjin) Co LtdCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsInfluenza B virus infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A